Acme Clinical Trials (ACT) is the largest database of clinical trials and studies worldwide. With more than 300,000 live studies accessible to users -- and thousands added daily -- ACT unifies a fragmented marketplace, bringing together insights, access and opportunities all in one comprehensive destination.
ACT was founded in 2017 by University of Cambridge graduates, who initially conceived of the platform during an alumni gathering. Since its initial inception, ACT has evolved into a dynamic platform powered by proprietary AI technology -- technology that enables patients, caregivers, physicians and researchers to search ACT databases, vet and apply for trials and review success rates and key learnings in real-time.
Launching in 2018, ACT will be 100% free to all users. This ensures those who need the platform most always have immediate access.
ACT is constantly growing, learning and improving each day. We welcome any suggestions to help improve the user experience. Contact us to share your story.
For more information, press inquiries or to post clinical studies, email us at [email protected]